Daniel Corey, Founder of Cero Therapeutics

Daniel Corey is the founder of Cero Therapeutics. Cero Therapeutics has raised $40M in total funding. Latest round: Series A.

About Daniel Corey

Daniel Corey is the co-founder of Cero Therapeutics, a clinical-stage biotechnology company based in San Francisco, California. The company focuses on developing engineered T-cell immunotherapies for hematological and solid tumor cancers. Cero Therapeutics has raised $40 million in Series A funding and went public on Nasdaq through a SPAC merger with Phoenix Biotech Acquisition Corp.

Daniel Corey at a glance

More founders in South San Francisco, United States (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library